Empowering Ultra-Rare Disease Patients to Pursue the Discovery of Treatments

Casey McPherson, chief innovation officer of Everlum Bio, discusses what led him to create the company, its “rare-disease-lab-as-a-service model, and how he is working to change the discovery landscape for ultra-rare disease therapies.